RELB and Miyoshi myopathy: To directly assess the status of RelB activation in MM patients, we performed EMSA combined with supershift analysis using anti-RelB antibody to evaluate RelB DNA-binding activity in 52 purified MM samples from newly diagnosed patients, and 2 purified healthy donors.